Abnormal overexpression of p53 is a predictive molecular biomarker
A common laboratory test that predicted poor outcome from traditional radiation and chemotherapy treatment for head and neck cancers now has been found to predict a good prognosis with treatment of p53 tumor suppressor gene therapy - making it potentially the first predictive biomarker test for a gene-based drug. Researchers at Introgen Therapeutics, Inc., in Austin, Texas, found that pati...Predictive medicine: Genes indicate diseases before symptoms do
Today, doctors still follow the same basic paradigm for healthcare, said William Clarke, executive...ApoCell's Cancer Predictive Index Helps Oncologists Select the Most Effective Targeted Drug Therapy
HOUSTON--(BUSINESS WIRE)--Jun 7, 2007 - ApoCell, Inc. presented theresults of a study conducted by researchers at the University ofChicago and ApoCell at the 2007 annual meeting of the AmericanSociety of Clinical Oncology (ASCO) held in Chicago in early June.The study showed that ApoCell's advanced pharmacodynamic biomarkerassay technology provides reliable predictive data of clinicalrespon...Indivumed Study Provides Sound Scientific Basis for a Predictive Drug Test- Platform
HAMBURG, Germany, May 03, 2007 /PRNewswire/ -- At the April AACRAnnual Meeting, Indivumed presented data which provide a soundscientific basis for a new drug test-platform to predict drugresponse in patients. Tumor tissue-derived primary cell lines are currently the firstchoice for cancer drug testing. During their clonal selection andexpansion, however, their gene and protein expr...